Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi

Bibliographic Details
Main Authors:	NIKITA SINGH, Juhi Shah, Vikramjit Kanwar, Shashikant Patne, Zachariah Chowdhury, Varun Shukla, Sambit Nanda
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124522004119

Similar Items

Кон Homi K. Bhabha (Ed.), Nation and Narration
by: Despina Angelovska, et al.
Published: (2002-01-01)

POSTKOLONIALISME DALAM ANTOLOGI CERPEN SEMUA UNTUK HINDIA KARYA IKSAKA BANU: KAJIAN TEORI HOMI K. BHABHA
by: Andaru Ratnasari, et al.
Published: (2024-05-01)

A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
by: Ryo Yonezawa, et al.
Published: (2023-01-01)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
by: Paolo Strati, et al.
Published: (2019-02-01)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
by: Bhanu Vakkalanka, et al.
Published: (2011-01-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
by: Adam F. Binder, et al.
Published: (2017-10-01)

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
by: J. P. Entrop, et al.
Published: (2022-06-01)

Os “brasis” de Luiz Ruffato, em Eles eram muitos cavalos: crítica ao discurso de nação à luz de Homi Bhabha
by: Eduardo Lopez Chagas
Published: (2019-09-01)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
by: Joshua P. Entrop, et al.
Published: (2022-10-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
by: Vojin Vukovic, et al.
Published: (2023-08-01)

Bhabha for architects /
by: Hernandez, Felipe, 1971-
Published: (2010)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
by: Alessandro Cellini, et al.
Published: (2024-09-01)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
by: Diego Villa, et al.
Published: (2018-12-01)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
by: Schwenkglenks Matthias, et al.
Published: (2010-08-01)

Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
by: Subbiah Vivek, et al.
Published: (2007-11-01)

Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil Linfoma de Hodgkin em estádio avançado: resultados do tratamento em 216 pacientes tratados com ABVD no Brasil
by: Luciana Britto, et al.
Published: (2010-01-01)

RESEÑA CRÍTICA SOBRE EL CONCEPTO DE TERCER ESPACIO DE HOMI BHABHA: DEL LOCAL DE LA CULTURA HASTA NUEVAS MINORÍAS, NUEVOS DERECHOS – NOTAS SOBRE COSMOPOLITISMO VERNÁCULOS
by: Catalina Revollo Pardo
Published: (2018-01-01)

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
by: Montoto, S, et al.
Published: (2011)

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
by: Orkin, C, et al.
Published: (2012)

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
by: Marriam Mponda, et al.
Published: (2024-03-01)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
by: Min Hu, et al.
Published: (2023-08-01)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
by: Heidi Mocikova, et al.
Published: (2022-10-01)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
by: Rogério Pinto Giesta, et al.
Published: (2009-06-01)

Diagnosis and treatment of Müllerian anomalies: Experience at the Fundación HOMI
by: Daniela Moreno Villamizar, et al.
Published: (2023-12-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
by: Arun Seshachalam, et al.
Published: (2019-12-01)

Whole-slide image analysis identifies a high content of Hodgkin Reed-Sternberg cells and a low content of T lymphocytes in tumor microenvironment as predictors of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD
by: Antonio Santisteban-Espejo, et al.
Published: (2022-10-01)

Bhabha atomic research centre annual report
Published: ([19-)

A STUDY OF BHABHA SCATTERING AT PETRA ENERGIES
by: Braunschweig, W, et al.
Published: (1988)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Published: (2018-10-01)

On Varanasi’s Tiny Temples
by: Christian Haskett
Published: (2018-04-01)

Skin Cancer in Varanasi
by: F. M. Tripathi, et al.
Published: (1977-07-01)

Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
by: Massimo Federico, et al.
Published: (2016-04-01)

NEW RESULTS FROM BHABHA SCATTERING AT 29 GEV
by: Derrick, M, et al.
Published: (1986)

Measurement of radiative Bhabha and quasi-real Compton scattering
by: Acciarri, M, et al.
Published: (1998)

Jacqueline Bhabha, Can We Solve the Migration Crisis?
by: Urszula Markowska-Manista
Published: (2019-09-01)

Constraints on antisymmetric tensor fields from Bhabha scattering
by: Siddharth Tiwary, et al.
Published: (2021-12-01)

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease
by: Mariavita Ciccarone, et al.
Published: (2023-04-01)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
by: Jillian R. Gunther, et al.
Published: (2020-07-01)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
by: Tawatchai Suwanban, et al.
Published: (2023-08-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)